NCT03139630View on ClinicalTrials.gov

COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients

CompletedOBSERVATIONAL

Enrollment

193

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

HIV SeropositivityDyslipidemiasPCSK9

Trial Locations (1)

75012

Cardiology Department, Saint Antoine University Hospital, Paris

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Agency for Research on AIDS and Viral Hepatitis (ANRS)

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Amgen

INDUSTRY

lead

Franck Boccara

OTHER

NCT03139630 - COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients | Biotech Hunter | Biotech Hunter